Trials / Completed
CompletedNCT03947112
Physical Activity Level of Norwegian Boys with Duchenne Muscular Dystrophy
Physical Activity Level of Norwegian Boys with Duchenne Muscular Dystrophy - a Cross Sectional Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 28 (actual)
- Sponsor
- Haukeland University Hospital · Academic / Other
- Sex
- Male
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this population based study is to examine, quantify and describe physical activity level in Norwegian boys with DMD, and to compare the level of physical activity level between boys with DMD and age matched healthy boys. A co-project will validate ActiGraph accelerometry to measure physical activity in boys with DMD.
Detailed description
International guidelines recommend regular physical activity for boys with DMD, and participation in physical activity plays a key role in the management. Paradoxically, patients with severe neuromuscular disease like DMD, have considerable limitations to participate in such activities. Limitation may be muscle weakness, pain, fatigue, reduced mobility and overall function, and also limited knowledge of physical activity benefits among health care personnel. Limited participation leads to a sedentary lifestyle, and gradual under-use of still functioning muscles may cause secondary deterioration in DMD. The current physical activity level amongst Norwegian DMD's are unknown, and physical activity registration and self-reported questionnaire will be examined in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Physical activity registration | At start, participants and parents fills out a Self-report questionnaire and the UngKan-3 Questionnaire, before a seven day physical activity registration takes place by use og ActiGraph. A physical activity diary are filled out every evening while the physical activity registration takes places. |
Timeline
- Start date
- 2020-08-20
- Primary completion
- 2021-06-30
- Completion
- 2021-06-30
- First posted
- 2019-05-13
- Last updated
- 2025-03-05
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT03947112. Inclusion in this directory is not an endorsement.